120 related articles for article (PubMed ID: 37171453)
1. Non-fasting lipids and cardiovascular disease in those with and without diabetes in Alberta's Tomorrow Project: A prospective cohort study.
Weaver OR; Ye M; Vena JE; Eurich DT; Proctor SD
Diabet Med; 2023 Sep; 40(9):e15133. PubMed ID: 37171453
[TBL] [Abstract][Full Text] [Related]
2. Anthropometric changes and risk of diabetes: are there sex differences? A longitudinal study of Alberta's Tomorrow Project.
Ye M; Robson PJ; Eurich DT; Vena JE; Xu JY; Johnson JA
BMJ Open; 2019 Jul; 9(7):e023829. PubMed ID: 31326923
[TBL] [Abstract][Full Text] [Related]
3. Remnant cholesterol, stronger than triglycerides, is associated with incident non-alcoholic fatty liver disease.
Cheng Y; Zhang Q; Li H; Zhou G; Shi P; Zhang X; Guan L; Yan F; Xu C
Front Endocrinol (Lausanne); 2023; 14():1098078. PubMed ID: 37214248
[TBL] [Abstract][Full Text] [Related]
4. Changes in body mass index and incidence of diabetes: A longitudinal study of Alberta's Tomorrow Project Cohort.
Ye M; Robson PJ; Eurich DT; Vena JE; Xu JY; Johnson JA
Prev Med; 2018 Jan; 106():157-163. PubMed ID: 29117506
[TBL] [Abstract][Full Text] [Related]
5. Chronic disease surveillance in Alberta's tomorrow project using administrative health data.
Ye M; Vena JE; Johnson JA; Shen-Tu G; Eurich DT
Int J Popul Data Sci; 2021; 6(1):1672. PubMed ID: 34734125
[TBL] [Abstract][Full Text] [Related]
6. Nonfasting remnant cholesterol and cardiovascular disease risk prediction in Albertans: a prospective cohort study.
Weaver OR; Krysa JA; Ye M; Vena JE; Eurich DT; Proctor SD
CMAJ Open; 2023; 11(4):E645-E653. PubMed ID: 37491049
[TBL] [Abstract][Full Text] [Related]
7. Systemic use of antibiotics and risk of diabetes in adults: A nested case-control study of Alberta's Tomorrow Project.
Ye M; Robson PJ; Eurich DT; Vena JE; Xu JY; Johnson JA
Diabetes Obes Metab; 2018 Apr; 20(4):849-857. PubMed ID: 29152889
[TBL] [Abstract][Full Text] [Related]
8. Administering a combination of online dietary assessment tools, the Automated Self-Administered 24-Hour Dietary Assessment Tool, and Diet History Questionnaire II, in a cohort of adults in Alberta's Tomorrow Project.
Solbak NM; Robson PJ; Lo Siou G; Al Rajabi A; Paek S; Vena JE; Kirkpatrick SI
J Acad Nutr Diet; 2021 Jul; 121(7):1312-1326. PubMed ID: 33612438
[TBL] [Abstract][Full Text] [Related]
9. The individual and combined effects of alcohol consumption and cigarette smoking on site-specific cancer risk in a prospective cohort of 26,607 adults: results from Alberta's Tomorrow Project.
Viner B; Barberio AM; Haig TR; Friedenreich CM; Brenner DR
Cancer Causes Control; 2019 Dec; 30(12):1313-1326. PubMed ID: 31535325
[TBL] [Abstract][Full Text] [Related]
10. Alcohol consumption and low-risk drinking guidelines among adults: a cross-sectional analysis from Alberta's Tomorrow Project.
Brenner DR; Haig TR; Poirier AE; Akawung A; Friedenreich CM; Robson PJ
Health Promot Chronic Dis Prev Can; 2017 Dec; 37(12):413-424. PubMed ID: 29236379
[TBL] [Abstract][Full Text] [Related]
11. Individual and Combined Cardiometabolic Morbidities and the Subsequent Risk of Cardiovascular Events in Chinese Adults.
Wang J; Wang Z; Guo F; Zhang Y; Ji H; Chen G; Wan Q; Yan L; Wang G; Qin Y; Luo Z; Tang X; Huo Y; Hu R; Ye Z; Shi L; Gao Z; Su Q; Mu Y; Zhao J; Chen L; Zeng T; Yu X; Li Q; Shen F; Chen L; Zhang Y; Wang Y; Deng H; Liu C; Wu S; Yang T; Li M; Xu Y; Xu M; Zhao Z; Wang T; Lu J; Bi Y; Wang W; Ning G; Zhao Y; Qin G
J Clin Endocrinol Metab; 2022 Jan; 107(1):e84-e94. PubMed ID: 34427675
[TBL] [Abstract][Full Text] [Related]
12. Lipid control and use of lipid-regulating drugs for prevention of cardiovascular events in Chinese type 2 diabetic patients: a prospective cohort study.
Ting RZ; Yang X; Yu LW; Luk AO; Kong AP; Tong PC; So WY; Chan JC; Ma RC
Cardiovasc Diabetol; 2010 Nov; 9():77. PubMed ID: 21092182
[TBL] [Abstract][Full Text] [Related]
13. The impact of dyslipidaemia on cardiovascular mortality in individuals without a prior history of diabetes in the DECODE Study.
Zhang L; Qiao Q; Tuomilehto J; Hammar N; Ruotolo G; Stehouwer CD; Heine RJ; Eliasson M; Zethelius B;
Atherosclerosis; 2009 Sep; 206(1):298-302. PubMed ID: 19303072
[TBL] [Abstract][Full Text] [Related]
14. Association of dairy consumption patterns with the incidence of type 2 diabetes: Findings from Alberta's Tomorrow Project.
Yuzbashian E; Pakseresht M; Vena J; Chan CB
Nutr Metab Cardiovasc Dis; 2022 Dec; 32(12):2760-2771. PubMed ID: 36333201
[TBL] [Abstract][Full Text] [Related]
15. Long-term Absolute Risk for Cardiovascular Disease Stratified by Fasting Glucose Level.
Bancks MP; Ning H; Allen NB; Bertoni AG; Carnethon MR; Correa A; Echouffo-Tcheugui JB; Lange LA; Lloyd-Jones DM; Wilkins JT
Diabetes Care; 2019 Mar; 42(3):457-465. PubMed ID: 30617142
[TBL] [Abstract][Full Text] [Related]
16. Elevated fasting total plasma homocysteine levels and cardiovascular disease outcomes in maintenance dialysis patients. A prospective study.
Bostom AG; Shemin D; Verhoef P; Nadeau MR; Jacques PF; Selhub J; Dworkin L; Rosenberg IH
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2554-8. PubMed ID: 9409227
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular Disease Risk Across a Spectrum of Adverse Plasma Lipid Combinations by Gender and Glycemic Status.
Liu X; Yang Y; Kang F; Li J; Zhou M; Ma X; Yu T; Zhang T; Xue F
Am J Cardiol; 2019 Sep; 124(5):702-708. PubMed ID: 31311663
[TBL] [Abstract][Full Text] [Related]
18. Fasting triglycerides are positively associated with cardiovascular mortality risk in people with diabetes.
Wang Y; Fang Y; Magliano DJ; Charchar FJ; Sobey CG; Drummond GR; Golledge J
Cardiovasc Res; 2023 May; 119(3):826-834. PubMed ID: 35905014
[TBL] [Abstract][Full Text] [Related]
19. Lipid measures for prediction of incident cardiovascular disease in diabetic and non-diabetic adults: results of the 8.6 years follow-up of a population based cohort study.
Tohidi M; Hatami M; Hadaegh F; Safarkhani M; Harati H; Azizi F
Lipids Health Dis; 2010 Jan; 9():6. PubMed ID: 20096127
[TBL] [Abstract][Full Text] [Related]
20. Remnant cholesterol as a risk factor for all-cause and cardiovascular mortality in incident peritoneal dialysis patients.
Deng J; Tang R; Chen J; Zhou Q; Zhan X; Long H; Peng F; Wang X; Wen Y; Feng X; Su N; Tang X; Tian N; Wu X; Xu Q
Nutr Metab Cardiovasc Dis; 2023 May; 33(5):1049-1056. PubMed ID: 36948938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
